GlucoTrack Stock (NASDAQ: GCTK) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 50.00 / 20.86K |
Day Range | - - - |
52 Wk Range | 0.66 - 4.95 |
Market Cap | $10.08M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 0.41% |
Days to Cover | 1.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GlucoTrack (NASDAQ:GCTK) through any online brokerage.
Other companies in GlucoTrack’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Bluejay Diagnostics (NASDAQ:BJDX) and Venus Concept (NASDAQ:VERO).
There is no analysis for GlucoTrack.
There is no analysis for GlucoTrack to provide a consensus price target.
The stock price for GlucoTrack (NASDAQ: GCTK) is $1.84 last updated July 16, 2024 at 7:32 AM EDT.
There are no upcoming dividends for GlucoTrack.
GlucoTrack’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for GlucoTrack.
GlucoTrack is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.